190 related articles for article (PubMed ID: 30037718)
1. Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis.
Chen Z; Zhan Y; Chi J; Guo S; Zhong X; He A; Zheng J; Gong Y; Li X; Zhou L
EBioMedicine; 2018 Aug; 34():94-107. PubMed ID: 30037718
[TBL] [Abstract][Full Text] [Related]
2. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.
Zhou H; Tang K; Xiao H; Zeng J; Guan W; Guo X; Xu H; Ye Z
J Exp Clin Cancer Res; 2015 May; 34(1):53. PubMed ID: 25991007
[TBL] [Abstract][Full Text] [Related]
3. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
[TBL] [Abstract][Full Text] [Related]
4. Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.
Sharma P; Saraya A; Sharma R
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e289-e301. PubMed ID: 29380534
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs and cancer: current state and future perspectives in urologic oncology.
Schaefer A; Jung M; Kristiansen G; Lein M; Schrader M; Miller K; Stephan C; Jung K
Urol Oncol; 2010; 28(1):4-13. PubMed ID: 19117772
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma.
Izquierdo L; Ingelmo-Torres M; Mallofré C; Lozano JJ; Verhasselt-Crinquette M; Leroy X; Colin P; Comperat E; Roupret M; Alcaraz A; Mengual L
BJU Int; 2014 May; 113(5):813-21. PubMed ID: 24180461
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
[TBL] [Abstract][Full Text] [Related]
8. Novel MicroRNA-Based Risk Score Identified by Integrated Analyses to Predict Metastasis and Poor Prognosis in Breast Cancer.
Kawaguchi T; Yan L; Qi Q; Peng X; Edge SB; Young J; Yao S; Liu S; Otsuji E; Takabe K
Ann Surg Oncol; 2018 Dec; 25(13):4037-4046. PubMed ID: 30311168
[TBL] [Abstract][Full Text] [Related]
9. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
10. Serum-Derived microRNAs as Prognostic Biomarkers in Osteosarcoma: A Meta-Analysis.
Luo H; Wang P; Ye H; Shi J; Dai L; Wang X; Song C; Zhang J; Li J
Front Genet; 2020; 11():789. PubMed ID: 32849795
[TBL] [Abstract][Full Text] [Related]
11. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
12. A panel of 13-miRNA signature as a potential biomarker for predicting survival in pancreatic cancer.
Zhou X; Huang Z; Xu L; Zhu M; Zhang L; Zhang H; Wang X; Li H; Zhu W; Shu Y; Liu P
Oncotarget; 2016 Oct; 7(43):69616-69624. PubMed ID: 27626307
[TBL] [Abstract][Full Text] [Related]
13. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
14. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.
Lánczky A; Nagy Á; Bottai G; Munkácsy G; Szabó A; Santarpia L; Győrffy B
Breast Cancer Res Treat; 2016 Dec; 160(3):439-446. PubMed ID: 27744485
[TBL] [Abstract][Full Text] [Related]
15. Genome-Wide miRNA Analysis Identifies miR-188-3p as a Novel Prognostic Marker and Molecular Factor Involved in Colorectal Carcinogenesis.
Pichler M; Stiegelbauer V; Vychytilova-Faltejskova P; Ivan C; Ling H; Winter E; Zhang X; Goblirsch M; Wulf-Goldenberg A; Ohtsuka M; Haybaeck J; Svoboda M; Okugawa Y; Gerger A; Hoefler G; Goel A; Slaby O; Calin GA
Clin Cancer Res; 2017 Mar; 23(5):1323-1333. PubMed ID: 27601590
[No Abstract] [Full Text] [Related]
16. Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer.
Prahm KP; Høgdall C; Karlsen MA; Christensen IJ; Novotny GW; Høgdall E
PLoS One; 2018; 13(11):e0207319. PubMed ID: 30475821
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
Catto JW; Alcaraz A; Bjartell AS; De Vere White R; Evans CP; Fussel S; Hamdy FC; Kallioniemi O; Mengual L; Schlomm T; Visakorpi T
Eur Urol; 2011 May; 59(5):671-81. PubMed ID: 21296484
[TBL] [Abstract][Full Text] [Related]
18. A 4-miRNA signature to predict survival in glioblastomas.
Hermansen SK; Sørensen MD; Hansen A; Knudsen S; Alvarado AG; Lathia JD; Kristensen BW
PLoS One; 2017; 12(11):e0188090. PubMed ID: 29136645
[TBL] [Abstract][Full Text] [Related]
19. Role of microRNAs in Predicting the Prognosis of Cervical Cancer Cases: A Systematic Review and Meta-Analysis.
Sabeena S; Ravishankar N
Asian Pac J Cancer Prev; 2021 Apr; 22(4):999-1006. PubMed ID: 33906290
[TBL] [Abstract][Full Text] [Related]
20. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]